158 related articles for article (PubMed ID: 18997440)
1. In vivo chemotherapeutic profile of human gallbladder small cell carcinoma.
Nishime C; Ohnishi Y; Suemizu H; Tamaoki N; Kusumi T; Sato F; Yamazaki H; Nakamura M; Ueyama Y; Kijima H
Biomed Res; 2008 Oct; 29(5):251-6. PubMed ID: 18997440
[TBL] [Abstract][Full Text] [Related]
2. New drugs for treating small cell lung cancer.
Ettinger DS
Lung Cancer; 1995 Jun; 12 Suppl 3():S53-61. PubMed ID: 7551957
[TBL] [Abstract][Full Text] [Related]
3. Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients.
Zhan M; Yang RM; Wang H; He M; Chen W; Xu SW; Yang LH; Liu Q; Long MM; Wang J
Cancer Commun (Lond); 2018 Jul; 38(1):48. PubMed ID: 30016995
[TBL] [Abstract][Full Text] [Related]
4. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia.
Mohamed F; Marchettini P; Stuart OA; Urano M; Sugarbaker PH
Ann Surg Oncol; 2003 May; 10(4):463-8. PubMed ID: 12734097
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.
Lissoni P; Brivio F; Fumagalli L; Messina G; Ghezzi V; Frontini L; Giani L; Vaghi M; Ardizzoia A; Gardani GS
Int J Biol Markers; 2004; 19(2):135-40. PubMed ID: 15255546
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice.
Mita Y; Ajiki T; Kamigaki T; Okazaki T; Hori H; Horiuchi H; Hirata K; Fujita T; Fujimori T; Kuroda Y
Ann Surg Oncol; 2007 Apr; 14(4):1374-80. PubMed ID: 17235714
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
Iwase R; Haruki K; Fujiwara Y; Furukawa K; Shiba H; Uwagawa T; Misawa T; Ohashi T; Yanaga K
J Surg Res; 2013 Sep; 184(1):605-12. PubMed ID: 23830367
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: a systematic review
.
Hann A; Nosalski E; Hermann PC; Egger J; Seufferlein T; Keller F
Clin Nephrol; 2018 Aug; 90(2):125-141. PubMed ID: 29578402
[TBL] [Abstract][Full Text] [Related]
9. [New drugs in gastrointestinal oncology. Current status and future directions].
Conroy T; Paillot B; Adenis A
Gastroenterol Clin Biol; 1999 Nov; 23(11):1145-65. PubMed ID: 10651534
[No Abstract] [Full Text] [Related]
10. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
Shi Y; Fan Y; Hu Y; Jing J; Wang C; Wu Y; Geng Q; Dong X; Li E; Dong D
J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
[TBL] [Abstract][Full Text] [Related]
11. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.
Zhang DC; Liu JL; Ding YB; Xia JG; Chen GY
Acta Pharmacol Sin; 2013 Feb; 34(2):301-8. PubMed ID: 23274410
[TBL] [Abstract][Full Text] [Related]
12. Gallbladder small cell carcinoma Xenograft established by serial transplantation in nude mice.
Nishime C; Ohnishi Y; Suemizu H; Tamaoki N; Suematsu M; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Kijima H
Anticancer Res; 2006; 26(1A):79-83. PubMed ID: 16475682
[TBL] [Abstract][Full Text] [Related]
13. Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts.
Iwai T; Moriya Y; Shirane M; Fujimoto-Ouchi K; Mori K
Oncol Rep; 2012 Apr; 27(4):923-8. PubMed ID: 22209766
[TBL] [Abstract][Full Text] [Related]
14. New chemotherapy agents for small cell lung cancer.
Kelly K
Chest; 2000 Apr; 117(4 Suppl 1):156S-162S. PubMed ID: 10777472
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine tumor of the gallbladder.
Elahi F; Ahmadzadeh A; Yadollahzadeh M; Hassanpour K; Babaei M
Arch Iran Med; 2013 Feb; 16(2):123-5. PubMed ID: 23360636
[TBL] [Abstract][Full Text] [Related]
16. [New promising anticancer drugs for lung cancer].
Ariyoshi Y; Sugiura T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2578-84. PubMed ID: 7979416
[TBL] [Abstract][Full Text] [Related]
17. New drug for therapy of non-small cell lung cancer.
Klastersky J
Lung Cancer; 1994 Nov; 11 Suppl 3():S139-49. PubMed ID: 7704506
[No Abstract] [Full Text] [Related]
18. Radiosensitization with chemotherapeutic agents.
Caffo O
Lung Cancer; 2001 Dec; 34 Suppl 4():S81-90. PubMed ID: 11742709
[TBL] [Abstract][Full Text] [Related]
19. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
[TBL] [Abstract][Full Text] [Related]
20. TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules.
Liu Q; Sun JD; Wang J; Ahluwalia D; Baker AF; Cranmer LD; Ferraro D; Wang Y; Duan JX; Ammons WS; Curd JG; Matteucci MD; Hart CP
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1487-98. PubMed ID: 22382881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
